151 Hemocyanin-N
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous non-metal compounds | 2 | 1.1 | 1.89× | not tested | |
| Organoheterocyclic compounds | 1 | 0.8 | 1.32× | not tested | |
| Organic acids and derivatives | 1 | 0.8 | 1.31× | not tested | |
| Homogeneous metal compounds | 3 | 2.4 | 1.24× | not tested | |
| Organic oxygen compounds | 1 | 1.0 | 1.02× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00145 | GLY | Glycine | 3 |
| DB00141 | NAG | N-Acetylglucosamine | 2 |
| DB09140 | OXY | Oxygen | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CUmetal | COPPER (II) ION | 12 |
| CL | CHLORIDE ION | 8 |
| GLY | GLYCINE | 3 |
| CUO | CU2-O2 CLUSTER | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| NAmetal | SODIUM ION | 1 |
| OXY | OXYGEN MOLECULE | 1 |
| PER | PEROXIDE ION | 1 |